Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain (original) (raw)

Nature Medicine volume 14, pages 331–336 (2008)Cite this article

Abstract

Treatment of neuropathic pain, triggered by multiple insults to the nervous system, is a clinical challenge because the underlying mechanisms of neuropathic pain development remain poorly understood1,2,3,4. Most treatments do not differentiate between different phases of neuropathic pain pathophysiology and simply focus on blocking neurotransmission, producing transient pain relief. Here, we report that early- and late-phase neuropathic pain development in rats and mice after nerve injury require different matrix metalloproteinases (MMPs). After spinal nerve ligation, MMP-9 shows a rapid and transient upregulation in injured dorsal root ganglion (DRG) primary sensory neurons consistent with an early phase of neuropathic pain, whereas MMP-2 shows a delayed response in DRG satellite cells and spinal astrocytes consistent with a late phase of neuropathic pain. Local inhibition of MMP-9 by an intrathecal route inhibits the early phase of neuropathic pain, whereas inhibition of MMP-2 suppresses the late phase of neuropathic pain. Further, intrathecal administration of MMP-9 or MMP-2 is sufficient to produce neuropathic pain symptoms. After nerve injury, MMP-9 induces neuropathic pain through interleukin-1β cleavage and microglial activation at early times, whereas MMP-2 maintains neuropathic pain through interleukin-1β cleavage and astrocyte activation at later times. Inhibition of MMP may provide a novel therapeutic approach for the treatment of neuropathic pain at different phases.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Ji, R.R. & Strichartz, G. Cell signaling and the genesis of neuropathic pain. Sci. STKE 2004, reE14 (2004).
    PubMed Google Scholar
  2. Tsuda, M., Inoue, K. & Salter, M.W. Neuropathic pain and spinal microglia: a big problem from molecules in “small” glia. Trends Neurosci. 28, 101–107 (2005).
    Article CAS Google Scholar
  3. Woolf, C.J. & Mannion, R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353, 1959–1964 (1999).
    Article CAS Google Scholar
  4. Kehlet, H., Jensen, T.S. & Woolf, C.J. Persistent postsurgical pain: risk factors and prevention. Lancet 367, 1618–1625 (2006).
    Article Google Scholar
  5. Parks, W.C., Wilson, C.L. & Lopez-Boado, Y.S. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4, 617–629 (2004).
    Article CAS Google Scholar
  6. Chattopadhyay, S., Myers, R.R., Janes, J. & Shubayev, V. Cytokine regulation of MMP-9 in peripheral glia: Implications for pathological processes and pain in injured nerve. Brain Behav. Immun. 21, 561–568 (2007).
    Article CAS Google Scholar
  7. Rosenberg, G.A. Matrix metalloproteinases in neuroinflammation. Glia 39, 279–291 (2002).
    Article Google Scholar
  8. Wang, X. et al. Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J. Neurosci. 20, 7037–7042 (2000).
    Article CAS Google Scholar
  9. Yong, V.W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat. Rev. Neurosci. 6, 931–944 (2005).
    Article CAS Google Scholar
  10. Zhao, B.Q. et al. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat. Med. 12, 441–445 (2006).
    Article CAS Google Scholar
  11. Kim, S.H. & Chung, J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50, 355–363 (1992).
    Article CAS Google Scholar
  12. Zhuang, Z.Y. et al. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J. Neurosci. 26, 3551–3560 (2006).
    Article CAS Google Scholar
  13. Levin, J.I. et al. The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines. Bioorg. Med. Chem. Lett. 11, 2975–2978 (2001).
    Article CAS Google Scholar
  14. Murphy, G. & Willenbrock, F. Tissue inhibitors of matrix metalloendopeptidases. Methods Enzymol. 248, 496–510 (1995).
    Article CAS Google Scholar
  15. Coull, J.A. et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438, 1017–1021 (2005).
    Article CAS Google Scholar
  16. Raghavendra, V., Tanga, F. & DeLeo, J.A. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J. Pharmacol. Exp. Ther. 306, 624–630 (2003).
    Article CAS Google Scholar
  17. Tsuda, M. et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778–783 (2003).
    Article CAS Google Scholar
  18. Watkins, L.R., Milligan, E.D. & Maier, S.F. Glial activation: a driving force for pathological pain. Trends Neurosci. 24, 450–455 (2001).
    Article CAS Google Scholar
  19. Jin, S.X., Zhuang, Z.Y., Woolf, C.J. & Ji, R.R. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 23, 4017–4022 (2003).
    Article CAS Google Scholar
  20. Schonbeck, U., Mach, F. & Libby, P. Generation of biologically active IL-1β by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1β processing. J. Immunol. 161, 3340–3346 (1998).
    CAS PubMed Google Scholar
  21. Samad, T.A. et al. Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410, 471–475 (2001).
    Article CAS Google Scholar
  22. Sweitzer, S., Martin, D. & DeLeo, J.A. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 103, 529–539 (2001).
    Article CAS Google Scholar
  23. Sung, C.-S. et al. Inhibition of p38 mitogen-activated protein kinase attenuates interleukin-1β-induced thermal hyperalgesia and inducible nitric oxide synthase expression in the spinal cord. J. Neurochem. 94, 742–752 (2005).
    Article CAS Google Scholar
  24. Clark, A.K. et al. Rapid co-release of interleukin 1β and caspase 1 in spinal cord inflammation. J. Neurochem. 99, 868–880 (2006).
    Article CAS Google Scholar
  25. Inoue, M. et al. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat. Med. 10, 712–718 (2004).
    Article CAS Google Scholar
  26. Zhuang, Z.Y., Gerner, P., Woolf, C.J. & Ji, R.R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114, 149–159 (2005).
    Article Google Scholar
  27. Dworkin, R.H. et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch. Neurol. 60, 1524–1534 (2003).
    Article Google Scholar
  28. Tan, P.H., Yang, L.C., Shih, H.C., Lan, K.C. & Cheng, J.T. Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. Gene Ther. 12, 59–66 (2005).
    Article CAS Google Scholar
  29. Chen, S. et al. Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss. Nat. Neurosci. 6, 1186–1193 (2003).
    Article CAS Google Scholar

Download references

Acknowledgements

The work was supported in part by US National Institutes of Health grants R01-DE17794, R01-NS54362 and TW7180 to R.-R.J. and R01-NS37074, R01-NS48422, R01-NS56458, P01-NS55104 and P50-NS10828 to E.H.L. P.-H.T. was supported by a grant from E-DA Hospital/I-Shou University, Taiwan. We thank T. Kohno (Niigata University, Japan) for providing FR167653 compound and Q. Ma (Harvard Medical School) for critical reading of the manuscript.

Author information

Author notes

  1. Yasuhiko Kawasaki, Zhen-Zhong Xu and Xiaoying Wang: These authors contributed equally to this study.

Authors and Affiliations

  1. Department of Anesthesiology, Pain Research Center, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Medical Research Building, Room 604, Boston, 02115, Massachusetts, USA
    Yasuhiko Kawasaki, Zhen-Zhong Xu, Jong Yeon Park, Zhi-Ye Zhuang, Ping-Heng Tan, Yong-Jing Gao & Ru-Rong Ji
  2. Departments of Neurology and Radiology, Neuroprotection Research Laboratory, Massachusetts General Hospital and Harvard Medical School, 149 13th Street, Charlestown, 02129, Massachusetts, USA
    Xiaoying Wang & Eng H Lo
  3. Division of Neuroscience, Children's Hospital and Harvard Medical School, 300 Longwood Avenue, Boston, 02115, Massachusetts, USA
    Kristine Roy & Gabriel Corfas

Authors

  1. Yasuhiko Kawasaki
    You can also search for this author inPubMed Google Scholar
  2. Zhen-Zhong Xu
    You can also search for this author inPubMed Google Scholar
  3. Xiaoying Wang
    You can also search for this author inPubMed Google Scholar
  4. Jong Yeon Park
    You can also search for this author inPubMed Google Scholar
  5. Zhi-Ye Zhuang
    You can also search for this author inPubMed Google Scholar
  6. Ping-Heng Tan
    You can also search for this author inPubMed Google Scholar
  7. Yong-Jing Gao
    You can also search for this author inPubMed Google Scholar
  8. Kristine Roy
    You can also search for this author inPubMed Google Scholar
  9. Gabriel Corfas
    You can also search for this author inPubMed Google Scholar
  10. Eng H Lo
    You can also search for this author inPubMed Google Scholar
  11. Ru-Rong Ji
    You can also search for this author inPubMed Google Scholar

Contributions

Y.K. performed behavioral and immunohistochemical experiments; Z.-Z.X. conducted western blotting, DRG culture and zymography studies; X.W. performed zymography studies and contributed to project development; J.Y.P. conducted behavioral studies; Z.-Y.Z. conducted initial behavioral and histochemical studies; P.-H.T. designed siRNAs and initially tested MMP-9 siRNA; Y.-J.G. conducted ELISA studies and prepared astrocyte cultures; K.R. and G.C. contributed to electron microscopy studies; E.H.L. developed the project and provided critical review and comments on the manuscript. R.-R.J. developed and supervised the project, designed all the experiments, conducted some data analysis and prepared the manuscript.

Corresponding author

Correspondence toRu-Rong Ji.

Supplementary information

Rights and permissions

About this article

Cite this article

Kawasaki, Y., Xu, ZZ., Wang, X. et al. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain.Nat Med 14, 331–336 (2008). https://doi.org/10.1038/nm1723

Download citation

This article is cited by

Associated content